WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

India's pharma ambitions are expanding. Are leadership capabilities keeping pace?

India makes more medicine than almost any country on earth. It is the third largest pharmaceutical producer in the world by volume and the single biggest supplier of generic medicines, accounting for roughly a fifth of global supply.

Raccontata daeconomictimes.indiatimes.comtimesofindia.indiatimes.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
timesofindia.indiatimes.comStai leggendo8 h fa

India's pharma ambitions are expanding. Are leadership capabilities keeping pace?

India makes more medicine than almost any country on earth. It is the third largest pharmaceutical producer in the world by volume and the single biggest supplier of generic medicines, accounting for roughly a fifth of…

originale
economictimes.indiatimes.com1 g fa

Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan Kulkarni

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. Companies are investing in advanced research and development. Global regulatory…

Leggi questa versione → originale

Timeline cronologica

  1. martedì 16 giugno 2026·economictimes.indiatimes.com

    Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan Kulkarni

    Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. Companies are investing in advanced…

  2. mercoledì 17 giugno 2026·economictimes.indiatimes.com

    Indian pharma market's double-digit growth momentum is likely to continue further: Equirus

    The Indian Pharmaceutical Market is set for continued double-digit growth. May's performance showed strong demand across all therapies. Chronic therapies are leading the…

  3. mercoledì 17 giugno 2026·timesofindia.indiatimes.com

    India's pharma ambitions are expanding. Are leadership capabilities keeping pace?

    India makes more medicine than almost any country on earth. It is the third largest pharmaceutical producer in the world by volume and the single biggest supplier of generic…